1. Therapeutic Vaccines Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Therapeutic Vaccines Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2025)
2.3.5. Company Locations
2.4. Leading Therapeutic Vaccines Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Therapeutic Vaccines Market: Dynamics
3.1. Therapeutic Vaccines Market Trends by Region
3.1.1. North America Therapeutic Vaccines Market Trends
3.1.2. Europe Therapeutic Vaccines Market Trends
3.1.3. Asia Pacific Therapeutic Vaccines Market Trends
3.1.4. Middle East and Africa Therapeutic Vaccines Market Trends
3.1.5. South America Therapeutic Vaccines Market Trends
3.2. Therapeutic Vaccines Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Therapeutic Vaccines Market Drivers
3.2.1.2. North America Therapeutic Vaccines Market Restraints
3.2.1.3. North America Therapeutic Vaccines Market Opportunities
3.2.1.4. North America Therapeutic Vaccines Market Challenges
3.2.2. Europe
3.2.2.1. Europe Therapeutic Vaccines Market Drivers
3.2.2.2. Europe Therapeutic Vaccines Market Restraints
3.2.2.3. Europe Therapeutic Vaccines Market Opportunities
3.2.2.4. Europe Therapeutic Vaccines Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Therapeutic Vaccines Market Drivers
3.2.3.2. Asia Pacific Therapeutic Vaccines Market Restraints
3.2.3.3. Asia Pacific Therapeutic Vaccines Market Opportunities
3.2.3.4. Asia Pacific Therapeutic Vaccines Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Therapeutic Vaccines Market Drivers
3.2.4.2. Middle East and Africa Therapeutic Vaccines Market Restraints
3.2.4.3. Middle East and Africa Therapeutic Vaccines Market Opportunities
3.2.4.4. Middle East and Africa Therapeutic Vaccines Market Challenges
3.2.5. South America
3.2.5.1. South America Therapeutic Vaccines Market Drivers
3.2.5.2. South America Therapeutic Vaccines Market Restraints
3.2.5.3. South America Therapeutic Vaccines Market Opportunities
3.2.5.4. South America Therapeutic Vaccines Market Challenges
3.3. PORTER's Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis in the Therapeutic Vaccines Market
3.8. Analysis of Government Schemes and Initiatives For Global Industry
3.9. Therapeutic Vaccines Market Trade Analysis
3.10. The Global Pandemic Impact on Therapeutic Vaccines Market
4. Therapeutic Vaccines Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
4.1. Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
4.1.1. Addiction Vaccines
4.1.2. Autoimmune Disease Vaccines
4.1.3. Infectious Disease Vaccines
4.1.4. Neurological Disease Vaccines
4.2. Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
4.2.1. Autologous vaccines
4.2.2. Allogeneic vaccines
4.3. Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
4.3.1. Tumour Cell Vaccines
4.3.2. Antigen/Peptide-based Vaccines
4.3.3. Dendritic Cell Vaccines
4.3.4. DNA Vaccines
4.3.5. RNA/mRNA-based Vaccines
4.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
4.3.7. Others
4.4. Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
4.4.1. Hospitals
4.4.2. Hospital Pharmacies
4.4.3. Retail Pharmacies
4.4.4. Online Pharmacies
4.5. Therapeutic Vaccines Market Size and Forecast, by Region (2025-2034)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Therapeutic Vaccines Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
5.1. North America Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
5.1.1. Addiction Vaccines
5.1.2. Autoimmune Disease Vaccines
5.1.3. Infectious Disease Vaccines
5.1.4. Neurological Disease Vaccines
5.2. North America Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
5.2.1. Autologous vaccines
5.2.2. Allogeneic vaccines
5.3. North America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
5.3.1. Tumour Cell Vaccines
5.3.2. Antigen/Peptide-based Vaccines
5.3.3. Dendritic Cell Vaccines
5.3.4. DNA Vaccines
5.3.5. RNA/mRNA-based Vaccines
5.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.3.7. Others
5.4. North America Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
5.4.1. Hospitals
5.4.2. Hospital Pharmacies
5.4.3. Retail Pharmacies
5.4.4. Online Pharmacies
5.5. North America Therapeutic Vaccines Market Size and Forecast, by Country (2025-2034)
5.5.1. United States
5.5.1.1. United States Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
5.5.1.1.1. Addiction Vaccines
5.5.1.1.2. Autoimmune Disease Vaccines
5.5.1.1.3. Infectious Disease Vaccines
5.5.1.1.4. Neurological Disease Vaccines
5.5.1.2. United States Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
5.5.1.2.1. Autologous vaccines
5.5.1.2.2. Allogeneic vaccines
5.5.1.3. United States Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
5.5.1.3.1. Tumour Cell Vaccines
5.5.1.3.2. Antigen/Peptide-based Vaccines
5.5.1.3.3. Dendritic Cell Vaccines
5.5.1.3.4. DNA Vaccines
5.5.1.3.5. RNA/mRNA-based Vaccines
5.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.1.3.7. Others
5.5.1.4. United States Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
5.5.1.4.1. Hospitals
5.5.1.4.2. Hospital Pharmacies
5.5.1.4.3. Retail Pharmacies
5.5.1.4.4. Online Pharmacies
5.5.2. Canada
5.5.2.1. Canada Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
5.5.2.1.1. Addiction Vaccines
5.5.2.1.2. Autoimmune Disease Vaccines
5.5.2.1.3. Infectious Disease Vaccines
5.5.2.1.4. Neurological Disease Vaccines
5.5.2.2. Canada Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
5.5.2.2.1. Autologous vaccines
5.5.2.2.2. Allogeneic vaccines
5.5.2.3. Canada Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
5.5.2.3.1. Tumour Cell Vaccines
5.5.2.3.2. Antigen/Peptide-based Vaccines
5.5.2.3.3. Dendritic Cell Vaccines
5.5.2.3.4. DNA Vaccines
5.5.2.3.5. RNA/mRNA-based Vaccines
5.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.2.3.7. Others
5.5.2.4. Canada Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
5.5.2.4.1. Hospitals
5.5.2.4.2. Hospital Pharmacies
5.5.2.4.3. Retail Pharmacies
5.5.2.4.4. Online Pharmacies
5.5.3. Mexico
5.5.3.1. Mexico Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
5.5.3.1.1. Addiction Vaccines
5.5.3.1.2. Autoimmune Disease Vaccines
5.5.3.1.3. Infectious Disease Vaccines
5.5.3.1.4. Neurological Disease Vaccines
5.5.3.2. Mexico Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
5.5.3.2.1. Autologous vaccines
5.5.3.2.2. Allogeneic vaccines
5.5.3.3. Mexico Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
5.5.3.3.1. Tumour Cell Vaccines
5.5.3.3.2. Antigen/Peptide-based Vaccines
5.5.3.3.3. Dendritic Cell Vaccines
5.5.3.3.4. DNA Vaccines
5.5.3.3.5. RNA/mRNA-based Vaccines
5.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
5.5.3.3.7. Others
5.5.3.4. Mexico Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
5.5.3.4.1. Hospitals
5.5.3.4.2. Hospital Pharmacies
5.5.3.4.3. Retail Pharmacies
5.5.3.4.4. Online Pharmacies
6. Europe Therapeutic Vaccines Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
6.1. Europe Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.1.1. Addiction Vaccines
6.1.2. Autoimmune Disease Vaccines
6.1.3. Infectious Disease Vaccines
6.1.4. Neurological Disease Vaccines
6.2. Europe Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.2.1. Autologous vaccines
6.2.2. Allogeneic vaccines
6.3. Europe Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.3.1. Tumour Cell Vaccines
6.3.2. Antigen/Peptide-based Vaccines
6.3.3. Dendritic Cell Vaccines
6.3.4. DNA Vaccines
6.3.5. RNA/mRNA-based Vaccines
6.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.3.7. Others
6.4. Europe Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.4.1. Hospitals
6.4.2. Hospital Pharmacies
6.4.3. Retail Pharmacies
6.4.4. Online Pharmacies
6.5. Europe Therapeutic Vaccines Market Size and Forecast, by Country (2025-2034)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.1.1.1. Addiction Vaccines
6.5.1.1.2. Autoimmune Disease Vaccines
6.5.1.1.3. Infectious Disease Vaccines
6.5.1.1.4. Neurological Disease Vaccines
6.5.1.2. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.1.2.1. Autologous vaccines
6.5.1.2.2. Allogeneic vaccines
6.5.1.3. United Kingdom Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.1.3.1. Tumour Cell Vaccines
6.5.1.3.2. Antigen/Peptide-based Vaccines
6.5.1.3.3. Dendritic Cell Vaccines
6.5.1.3.4. DNA Vaccines
6.5.1.3.5. RNA/mRNA-based Vaccines
6.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.1.3.7. Others
6.5.1.4. United Kingdom Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.1.4.1. Hospitals
6.5.1.4.2. Hospital Pharmacies
6.5.1.4.3. Retail Pharmacies
6.5.1.4.4. Online Pharmacies
6.5.2. France
6.5.2.1. France Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.2.1.1. Addiction Vaccines
6.5.2.1.2. Autoimmune Disease Vaccines
6.5.2.1.3. Infectious Disease Vaccines
6.5.2.1.4. Neurological Disease Vaccines
6.5.2.2. France Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.2.2.1. Autologous vaccines
6.5.2.2.2. Allogeneic vaccines
6.5.2.3. France Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.2.3.1. Tumour Cell Vaccines
6.5.2.3.2. Antigen/Peptide-based Vaccines
6.5.2.3.3. Dendritic Cell Vaccines
6.5.2.3.4. DNA Vaccines
6.5.2.3.5. RNA/mRNA-based Vaccines
6.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.2.3.7. Others
6.5.2.4. France Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.2.4.1. Hospitals
6.5.2.4.2. Hospital Pharmacies
6.5.2.4.3. Retail Pharmacies
6.5.2.4.4. Online Pharmacies
6.5.3. Germany
6.5.3.1. Germany Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.3.1.1. Addiction Vaccines
6.5.3.1.2. Autoimmune Disease Vaccines
6.5.3.1.3. Infectious Disease Vaccines
6.5.3.1.4. Neurological Disease Vaccines
6.5.3.2. Germany Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.3.2.1. Autologous vaccines
6.5.3.2.2. Allogeneic vaccines
6.5.3.3. Germany Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.3.3.1. Tumour Cell Vaccines
6.5.3.3.2. Antigen/Peptide-based Vaccines
6.5.3.3.3. Dendritic Cell Vaccines
6.5.3.3.4. DNA Vaccines
6.5.3.3.5. RNA/mRNA-based Vaccines
6.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.3.3.7. Others
6.5.3.4. Germany Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.3.4.1. Hospitals
6.5.3.4.2. Hospital Pharmacies
6.5.3.4.3. Retail Pharmacies
6.5.3.4.4. Online Pharmacies
6.5.4. Italy
6.5.4.1. Italy Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.4.1.1. Addiction Vaccines
6.5.4.1.2. Autoimmune Disease Vaccines
6.5.4.1.3. Infectious Disease Vaccines
6.5.4.1.4. Neurological Disease Vaccines
6.5.4.2. Italy Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.4.2.1. Autologous vaccines
6.5.4.2.2. Allogeneic vaccines
6.5.4.3. Italy Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.4.3.1. Tumour Cell Vaccines
6.5.4.3.2. Antigen/Peptide-based Vaccines
6.5.4.3.3. Dendritic Cell Vaccines
6.5.4.3.4. DNA Vaccines
6.5.4.3.5. RNA/mRNA-based Vaccines
6.5.4.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.4.3.7. Others
6.5.4.4. Italy Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.4.4.1. Hospitals
6.5.4.4.2. Hospital Pharmacies
6.5.4.4.3. Retail Pharmacies
6.5.4.4.4. Online Pharmacies
6.5.5. Spain
6.5.5.1. Spain Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.5.1.1. Addiction Vaccines
6.5.5.1.2. Autoimmune Disease Vaccines
6.5.5.1.3. Infectious Disease Vaccines
6.5.5.1.4. Neurological Disease Vaccines
6.5.5.2. Spain Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.5.2.1. Autologous vaccines
6.5.5.2.2. Allogeneic vaccines
6.5.5.3. Spain Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.5.3.1. Tumour Cell Vaccines
6.5.5.3.2. Antigen/Peptide-based Vaccines
6.5.5.3.3. Dendritic Cell Vaccines
6.5.5.3.4. DNA Vaccines
6.5.5.3.5. RNA/mRNA-based Vaccines
6.5.5.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.5.3.7. Others
6.5.5.4. Spain Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.5.4.1. Hospitals
6.5.5.4.2. Hospital Pharmacies
6.5.5.4.3. Retail Pharmacies
6.5.5.4.4. Online Pharmacies
6.5.6. Sweden
6.5.6.1. Sweden Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.6.1.1. Addiction Vaccines
6.5.6.1.2. Autoimmune Disease Vaccines
6.5.6.1.3. Infectious Disease Vaccines
6.5.6.1.4. Neurological Disease Vaccines
6.5.6.2. Sweden Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.6.2.1. Autologous vaccines
6.5.6.2.2. Allogeneic vaccines
6.5.6.3. Sweden Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.6.3.1. Tumour Cell Vaccines
6.5.6.3.2. Antigen/Peptide-based Vaccines
6.5.6.3.3. Dendritic Cell Vaccines
6.5.6.3.4. DNA Vaccines
6.5.6.3.5. RNA/mRNA-based Vaccines
6.5.6.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.6.3.7. Others
6.5.6.4. Sweden Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.6.4.1. Hospitals
6.5.6.4.2. Hospital Pharmacies
6.5.6.4.3. Retail Pharmacies
6.5.6.4.4. Online Pharmacies
6.5.7. Austria
6.5.7.1. Austria Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.7.1.1. Addiction Vaccines
6.5.7.1.2. Autoimmune Disease Vaccines
6.5.7.1.3. Infectious Disease Vaccines
6.5.7.1.4. Neurological Disease Vaccines
6.5.7.2. Austria Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.7.2.1. Autologous vaccines
6.5.7.2.2. Allogeneic vaccines
6.5.7.3. Austria Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.7.3.1. Tumour Cell Vaccines
6.5.7.3.2. Antigen/Peptide-based Vaccines
6.5.7.3.3. Dendritic Cell Vaccines
6.5.7.3.4. DNA Vaccines
6.5.7.3.5. RNA/mRNA-based Vaccines
6.5.7.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.7.3.7. Others
6.5.7.4. Austria Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.7.4.1. Hospitals
6.5.7.4.2. Hospital Pharmacies
6.5.7.4.3. Retail Pharmacies
6.5.7.4.4. Online Pharmacies
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
6.5.8.1.1. Addiction Vaccines
6.5.8.1.2. Autoimmune Disease Vaccines
6.5.8.1.3. Infectious Disease Vaccines
6.5.8.1.4. Neurological Disease Vaccines
6.5.8.2. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
6.5.8.2.1. Autologous vaccines
6.5.8.2.2. Allogeneic vaccines
6.5.8.3. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
6.5.8.3.1. Tumour Cell Vaccines
6.5.8.3.2. Antigen/Peptide-based Vaccines
6.5.8.3.3. Dendritic Cell Vaccines
6.5.8.3.4. DNA Vaccines
6.5.8.3.5. RNA/mRNA-based Vaccines
6.5.8.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
6.5.8.3.7. Others
6.5.8.4. Rest of Europe Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
6.5.8.4.1. Hospitals
6.5.8.4.2. Hospital Pharmacies
6.5.8.4.3. Retail Pharmacies
6.5.8.4.4. Online Pharmacies
7. Asia Pacific Therapeutic Vaccines Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
7.1. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.1.1. Addiction Vaccines
7.1.2. Autoimmune Disease Vaccines
7.1.3. Infectious Disease Vaccines
7.1.4. Neurological Disease Vaccines
7.2. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.2.1. Autologous vaccines
7.2.2. Allogeneic vaccines
7.3. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.3.1. Tumour Cell Vaccines
7.3.2. Antigen/Peptide-based Vaccines
7.3.3. Dendritic Cell Vaccines
7.3.4. DNA Vaccines
7.3.5. RNA/mRNA-based Vaccines
7.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.3.7. Others
7.4. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.4.1. Hospitals
7.4.2. Hospital Pharmacies
7.4.3. Retail Pharmacies
7.4.4. Online Pharmacies
7.5. Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Country (2025-2034)
7.5.1. China
7.5.1.1. China Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.1.1.1. Addiction Vaccines
7.5.1.1.2. Autoimmune Disease Vaccines
7.5.1.1.3. Infectious Disease Vaccines
7.5.1.1.4. Neurological Disease Vaccines
7.5.1.2. China Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.1.2.1. Autologous vaccines
7.5.1.2.2. Allogeneic vaccines
7.5.1.3. China Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.1.3.1. Tumour Cell Vaccines
7.5.1.3.2. Antigen/Peptide-based Vaccines
7.5.1.3.3. Dendritic Cell Vaccines
7.5.1.3.4. DNA Vaccines
7.5.1.3.5. RNA/mRNA-based Vaccines
7.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.1.3.7. Others
7.5.1.4. China Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.1.4.1. Hospitals
7.5.1.4.2. Hospital Pharmacies
7.5.1.4.3. Retail Pharmacies
7.5.1.4.4. Online Pharmacies
7.5.2. S Korea
7.5.2.1. S Korea Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.2.1.1. Addiction Vaccines
7.5.2.1.2. Autoimmune Disease Vaccines
7.5.2.1.3. Infectious Disease Vaccines
7.5.2.1.4. Neurological Disease Vaccines
7.5.2.2. S Korea Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.2.2.1. Autologous vaccines
7.5.2.2.2. Allogeneic vaccines
7.5.2.3. S Korea Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.2.3.1. Tumour Cell Vaccines
7.5.2.3.2. Antigen/Peptide-based Vaccines
7.5.2.3.3. Dendritic Cell Vaccines
7.5.2.3.4. DNA Vaccines
7.5.2.3.5. RNA/mRNA-based Vaccines
7.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.2.3.7. Others
7.5.2.4. S Korea Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.2.4.1. Hospitals
7.5.2.4.2. Hospital Pharmacies
7.5.2.4.3. Retail Pharmacies
7.5.2.4.4. Online Pharmacies
7.5.3. Japan
7.5.3.1. Japan Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.3.1.1. Addiction Vaccines
7.5.3.1.2. Autoimmune Disease Vaccines
7.5.3.1.3. Infectious Disease Vaccines
7.5.3.1.4. Neurological Disease Vaccines
7.5.3.2. Japan Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.3.2.1. Autologous vaccines
7.5.3.2.2. Allogeneic vaccines
7.5.3.3. Japan Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.3.3.1. Tumour Cell Vaccines
7.5.3.3.2. Antigen/Peptide-based Vaccines
7.5.3.3.3. Dendritic Cell Vaccines
7.5.3.3.4. DNA Vaccines
7.5.3.3.5. RNA/mRNA-based Vaccines
7.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.3.3.7. Others
7.5.3.4. Japan Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.3.4.1. Hospitals
7.5.3.4.2. Hospital Pharmacies
7.5.3.4.3. Retail Pharmacies
7.5.3.4.4. Online Pharmacies
7.5.4. India
7.5.4.1. India Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.4.1.1. Addiction Vaccines
7.5.4.1.2. Autoimmune Disease Vaccines
7.5.4.1.3. Infectious Disease Vaccines
7.5.4.1.4. Neurological Disease Vaccines
7.5.4.2. India Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.4.2.1. Autologous vaccines
7.5.4.2.2. Allogeneic vaccines
7.5.4.3. India Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.4.3.1. Tumour Cell Vaccines
7.5.4.3.2. Antigen/Peptide-based Vaccines
7.5.4.3.3. Dendritic Cell Vaccines
7.5.4.3.4. DNA Vaccines
7.5.4.3.5. RNA/mRNA-based Vaccines
7.5.4.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.4.3.7. Others
7.5.4.4. India Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.4.4.1. Hospitals
7.5.4.4.2. Hospital Pharmacies
7.5.4.4.3. Retail Pharmacies
7.5.4.4.4. Online Pharmacies
7.5.5. Australia
7.5.5.1. Australia Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.5.1.1. Addiction Vaccines
7.5.5.1.2. Autoimmune Disease Vaccines
7.5.5.1.3. Infectious Disease Vaccines
7.5.5.1.4. Neurological Disease Vaccines
7.5.5.2. Australia Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.5.2.1. Autologous vaccines
7.5.5.2.2. Allogeneic vaccines
7.5.5.3. Australia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.5.3.1. Tumour Cell Vaccines
7.5.5.3.2. Antigen/Peptide-based Vaccines
7.5.5.3.3. Dendritic Cell Vaccines
7.5.5.3.4. DNA Vaccines
7.5.5.3.5. RNA/mRNA-based Vaccines
7.5.5.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.5.3.7. Others
7.5.5.4. Australia Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.5.4.1. Hospitals
7.5.5.4.2. Hospital Pharmacies
7.5.5.4.3. Retail Pharmacies
7.5.5.4.4. Online Pharmacies
7.5.6. Indonesia
7.5.6.1. Indonesia Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.6.1.1. Addiction Vaccines
7.5.6.1.2. Autoimmune Disease Vaccines
7.5.6.1.3. Infectious Disease Vaccines
7.5.6.1.4. Neurological Disease Vaccines
7.5.6.2. Indonesia Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.6.2.1. Autologous vaccines
7.5.6.2.2. Allogeneic vaccines
7.5.6.3. Indonesia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.6.3.1. Tumour Cell Vaccines
7.5.6.3.2. Antigen/Peptide-based Vaccines
7.5.6.3.3. Dendritic Cell Vaccines
7.5.6.3.4. DNA Vaccines
7.5.6.3.5. RNA/mRNA-based Vaccines
7.5.6.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.6.3.7. Others
7.5.6.4. Indonesia Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.6.4.1. Hospitals
7.5.6.4.2. Hospital Pharmacies
7.5.6.4.3. Retail Pharmacies
7.5.6.4.4. Online Pharmacies
7.5.7. Malaysia
7.5.7.1. Malaysia Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.7.1.1. Addiction Vaccines
7.5.7.1.2. Autoimmune Disease Vaccines
7.5.7.1.3. Infectious Disease Vaccines
7.5.7.1.4. Neurological Disease Vaccines
7.5.7.2. Malaysia Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.7.2.1. Autologous vaccines
7.5.7.2.2. Allogeneic vaccines
7.5.7.3. Malaysia Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.7.3.1. Tumour Cell Vaccines
7.5.7.3.2. Antigen/Peptide-based Vaccines
7.5.7.3.3. Dendritic Cell Vaccines
7.5.7.3.4. DNA Vaccines
7.5.7.3.5. RNA/mRNA-based Vaccines
7.5.7.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.7.3.7. Others
7.5.7.4. Malaysia Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.7.4.1. Hospitals
7.5.7.4.2. Hospital Pharmacies
7.5.7.4.3. Retail Pharmacies
7.5.7.4.4. Online Pharmacies
7.5.8. Vietnam
7.5.8.1. Vietnam Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.8.1.1. Addiction Vaccines
7.5.8.1.2. Autoimmune Disease Vaccines
7.5.8.1.3. Infectious Disease Vaccines
7.5.8.1.4. Neurological Disease Vaccines
7.5.8.2. Vietnam Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.8.2.1. Autologous vaccines
7.5.8.2.2. Allogeneic vaccines
7.5.8.3. Vietnam Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.8.3.1. Tumour Cell Vaccines
7.5.8.3.2. Antigen/Peptide-based Vaccines
7.5.8.3.3. Dendritic Cell Vaccines
7.5.8.3.4. DNA Vaccines
7.5.8.3.5. RNA/mRNA-based Vaccines
7.5.8.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.8.3.7. Others
7.5.8.4. Vietnam Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.8.4.1. Hospitals
7.5.8.4.2. Hospital Pharmacies
7.5.8.4.3. Retail Pharmacies
7.5.8.4.4. Online Pharmacies
7.5.9. Taiwan
7.5.9.1. Taiwan Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.9.1.1. Addiction Vaccines
7.5.9.1.2. Autoimmune Disease Vaccines
7.5.9.1.3. Infectious Disease Vaccines
7.5.9.1.4. Neurological Disease Vaccines
7.5.9.2. Taiwan Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.9.2.1. Autologous vaccines
7.5.9.2.2. Allogeneic vaccines
7.5.9.3. Taiwan Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.9.3.1. Tumour Cell Vaccines
7.5.9.3.2. Antigen/Peptide-based Vaccines
7.5.9.3.3. Dendritic Cell Vaccines
7.5.9.3.4. DNA Vaccines
7.5.9.3.5. RNA/mRNA-based Vaccines
7.5.9.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.9.3.7. Others
7.5.9.4. Taiwan Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.9.4.1. Hospitals
7.5.9.4.2. Hospital Pharmacies
7.5.9.4.3. Retail Pharmacies
7.5.9.4.4. Online Pharmacies
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
7.5.10.1.1. Addiction Vaccines
7.5.10.1.2. Autoimmune Disease Vaccines
7.5.10.1.3. Infectious Disease Vaccines
7.5.10.1.4. Neurological Disease Vaccines
7.5.10.2. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
7.5.10.2.1. Autologous vaccines
7.5.10.2.2. Allogeneic vaccines
7.5.10.3. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
7.5.10.3.1. Tumour Cell Vaccines
7.5.10.3.2. Antigen/Peptide-based Vaccines
7.5.10.3.3. Dendritic Cell Vaccines
7.5.10.3.4. DNA Vaccines
7.5.10.3.5. RNA/mRNA-based Vaccines
7.5.10.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
7.5.10.3.7. Others
7.5.10.4. Rest of Asia Pacific Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
7.5.10.4.1. Hospitals
7.5.10.4.2. Hospital Pharmacies
7.5.10.4.3. Retail Pharmacies
7.5.10.4.4. Online Pharmacies
8. Middle East and Africa Therapeutic Vaccines Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
8.1. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
8.1.1. Addiction Vaccines
8.1.2. Autoimmune Disease Vaccines
8.1.3. Infectious Disease Vaccines
8.1.4. Neurological Disease Vaccines
8.2. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
8.2.1. Autologous vaccines
8.2.2. Allogeneic vaccines
8.3. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
8.3.1. Tumour Cell Vaccines
8.3.2. Antigen/Peptide-based Vaccines
8.3.3. Dendritic Cell Vaccines
8.3.4. DNA Vaccines
8.3.5. RNA/mRNA-based Vaccines
8.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
8.3.7. Others
8.4. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
8.4.1. Hospitals
8.4.2. Hospital Pharmacies
8.4.3. Retail Pharmacies
8.4.4. Online Pharmacies
8.5. Middle East and Africa Therapeutic Vaccines Market Size and Forecast, by Country (2025-2034)
8.5.1. South Africa
8.5.1.1. South Africa Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
8.5.1.1.1. Addiction Vaccines
8.5.1.1.2. Autoimmune Disease Vaccines
8.5.1.1.3. Infectious Disease Vaccines
8.5.1.1.4. Neurological Disease Vaccines
8.5.1.2. South Africa Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
8.5.1.2.1. Autologous vaccines
8.5.1.2.2. Allogeneic vaccines
8.5.1.3. South Africa Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
8.5.1.3.1. Tumour Cell Vaccines
8.5.1.3.2. Antigen/Peptide-based Vaccines
8.5.1.3.3. Dendritic Cell Vaccines
8.5.1.3.4. DNA Vaccines
8.5.1.3.5. RNA/mRNA-based Vaccines
8.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
8.5.1.3.7. Others
8.5.1.4. South Africa Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
8.5.1.4.1. Hospitals
8.5.1.4.2. Hospital Pharmacies
8.5.1.4.3. Retail Pharmacies
8.5.1.4.4. Online Pharmacies
8.5.2. GCC
8.5.2.1. GCC Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
8.5.2.1.1. Addiction Vaccines
8.5.2.1.2. Autoimmune Disease Vaccines
8.5.2.1.3. Infectious Disease Vaccines
8.5.2.1.4. Neurological Disease Vaccines
8.5.2.2. GCC Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
8.5.2.2.1. Autologous vaccines
8.5.2.2.2. Allogeneic vaccines
8.5.2.3. GCC Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
8.5.2.3.1. Tumour Cell Vaccines
8.5.2.3.2. Antigen/Peptide-based Vaccines
8.5.2.3.3. Dendritic Cell Vaccines
8.5.2.3.4. DNA Vaccines
8.5.2.3.5. RNA/mRNA-based Vaccines
8.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
8.5.2.3.7. Others
8.5.2.4. GCC Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
8.5.2.4.1. Hospitals
8.5.2.4.2. Hospital Pharmacies
8.5.2.4.3. Retail Pharmacies
8.5.2.4.4. Online Pharmacies
8.5.3. Nigeria
8.5.3.1. Nigeria Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
8.5.3.1.1. Addiction Vaccines
8.5.3.1.2. Autoimmune Disease Vaccines
8.5.3.1.3. Infectious Disease Vaccines
8.5.3.1.4. Neurological Disease Vaccines
8.5.3.2. Nigeria Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
8.5.3.2.1. Autologous vaccines
8.5.3.2.2. Allogeneic vaccines
8.5.3.3. Nigeria Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
8.5.3.3.1. Tumour Cell Vaccines
8.5.3.3.2. Antigen/Peptide-based Vaccines
8.5.3.3.3. Dendritic Cell Vaccines
8.5.3.3.4. DNA Vaccines
8.5.3.3.5. RNA/mRNA-based Vaccines
8.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
8.5.3.3.7. Others
8.5.3.4. Nigeria Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
8.5.3.4.1. Hospitals
8.5.3.4.2. Hospital Pharmacies
8.5.3.4.3. Retail Pharmacies
8.5.3.4.4. Online Pharmacies
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
8.5.4.1.1. Addiction Vaccines
8.5.4.1.2. Autoimmune Disease Vaccines
8.5.4.1.3. Infectious Disease Vaccines
8.5.4.1.4. Neurological Disease Vaccines
8.5.4.2. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
8.5.4.2.1. Autologous vaccines
8.5.4.2.2. Allogeneic vaccines
8.5.4.3. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
8.5.4.3.1. Tumour Cell Vaccines
8.5.4.3.2. Antigen/Peptide-based Vaccines
8.5.4.3.3. Dendritic Cell Vaccines
8.5.4.3.4. DNA Vaccines
8.5.4.3.5. RNA/mRNA-based Vaccines
8.5.4.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
8.5.4.3.7. Others
8.5.4.4. Rest of ME&A Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
8.5.4.4.1. Hospitals
8.5.4.4.2. Hospital Pharmacies
8.5.4.4.3. Retail Pharmacies
8.5.4.4.4. Online Pharmacies
9. South America Therapeutic Vaccines Market Size and Forecast by Segmentation (in USD Billion) 2025-2034
9.1. South America Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
9.1.1. Addiction Vaccines
9.1.2. Autoimmune Disease Vaccines
9.1.3. Infectious Disease Vaccines
9.1.4. Neurological Disease Vaccines
9.2. South America Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
9.2.1. Autologous vaccines
9.2.2. Allogeneic vaccines
9.3. South America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
9.3.1. Tumour Cell Vaccines
9.3.2. Antigen/Peptide-based Vaccines
9.3.3. Dendritic Cell Vaccines
9.3.4. DNA Vaccines
9.3.5. RNA/mRNA-based Vaccines
9.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
9.3.7. Others
9.4. South America Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
9.4.1. Hospitals
9.4.2. Hospital Pharmacies
9.4.3. Retail Pharmacies
9.4.4. Online Pharmacies
9.5. South America Therapeutic Vaccines Market Size and Forecast, by Country (2025-2034)
9.5.1. Brazil
9.5.1.1. Brazil Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
9.5.1.1.1. Addiction Vaccines
9.5.1.1.2. Autoimmune Disease Vaccines
9.5.1.1.3. Infectious Disease Vaccines
9.5.1.1.4. Neurological Disease Vaccines
9.5.1.2. Brazil Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
9.5.1.2.1. Autologous vaccines
9.5.1.2.2. Allogeneic vaccines
9.5.1.3. Brazil Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
9.5.1.3.1. Tumour Cell Vaccines
9.5.1.3.2. Antigen/Peptide-based Vaccines
9.5.1.3.3. Dendritic Cell Vaccines
9.5.1.3.4. DNA Vaccines
9.5.1.3.5. RNA/mRNA-based Vaccines
9.5.1.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
9.5.1.3.7. Others
9.5.1.4. Brazil Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
9.5.1.4.1. Hospitals
9.5.1.4.2. Hospital Pharmacies
9.5.1.4.3. Retail Pharmacies
9.5.1.4.4. Online Pharmacies
9.5.2. Argentina
9.5.2.1. Argentina Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
9.5.2.1.1. Addiction Vaccines
9.5.2.1.2. Autoimmune Disease Vaccines
9.5.2.1.3. Infectious Disease Vaccines
9.5.2.1.4. Neurological Disease Vaccines
9.5.2.2. Argentina Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
9.5.2.2.1. Autologous vaccines
9.5.2.2.2. Allogeneic vaccines
9.5.2.3. Argentina Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
9.5.2.3.1. Tumour Cell Vaccines
9.5.2.3.2. Antigen/Peptide-based Vaccines
9.5.2.3.3. Dendritic Cell Vaccines
9.5.2.3.4. DNA Vaccines
9.5.2.3.5. RNA/mRNA-based Vaccines
9.5.2.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
9.5.2.3.7. Others
9.5.2.4. Argentina Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
9.5.2.4.1. Hospitals
9.5.2.4.2. Hospital Pharmacies
9.5.2.4.3. Retail Pharmacies
9.5.2.4.4. Online Pharmacies
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Product (2025-2034)
9.5.3.1.1. Addiction Vaccines
9.5.3.1.2. Autoimmune Disease Vaccines
9.5.3.1.3. Infectious Disease Vaccines
9.5.3.1.4. Neurological Disease Vaccines
9.5.3.2. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Technology (2025-2034)
9.5.3.2.1. Autologous vaccines
9.5.3.2.2. Allogeneic vaccines
9.5.3.3. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by Vaccine Type (2025-2034)
9.5.3.3.1. Tumour Cell Vaccines
9.5.3.3.2. Antigen/Peptide-based Vaccines
9.5.3.3.3. Dendritic Cell Vaccines
9.5.3.3.4. DNA Vaccines
9.5.3.3.5. RNA/mRNA-based Vaccines
9.5.3.3.6. Virus-like Particle (VLP) / Vector-based Vaccines
9.5.3.3.7. Others
9.5.3.4. Rest Of South America Therapeutic Vaccines Market Size and Forecast, by End-User (2025-2034)
9.5.3.4.1. Hospitals
9.5.3.4.2. Hospital Pharmacies
9.5.3.4.3. Retail Pharmacies
9.5.3.4.4. Online Pharmacies
10. Company Profile: Key Players
10.1. Sanofi-Pasteur
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. Cytos Biotechnology AG
10.3. Intellect Neurosciences
10.4. Agenus Inc.
10.5. Celtic Pharma,
10.6. Novartis
10.7. Dendreon Corp.
10.8. Pfizer
10.9. Transgene
10.10. Antigenics
10.11. Argos Therapeutics
10.12. Bavarian Nordic
10.13. Biovest International
10.14. Celldex Therapeutics
10.15. Cel-Sci
10.16. Curevac
10.17. GlaxoSmithKline
10.18. Merck & Co.
10.19. Vaccinogen Inc.
10.20. Affiris
10.21. Medimmune, LLC
11. Key Findings
12. Industry Recommendations
13. Therapeutic Vaccines Market: Research Methodology
14. Terms and Glossary